| Department of Medicine

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

Intrapulmonary pharmacokinetics of linezolid.

Response of authors to Ganju and Dias' comments on 'Inclusion of Placebos and Blinding for Ascending Dose First-in-Human Studies and Other Underpowered Phase 1 Studies Has Not Been Justified and on Balance is Not Useful' by D. A. Parasrampuria and L. Z. B

Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial.

James Ryan, MD

Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis.

Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.

A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT.

Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis.

Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.

PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.

Measurement of the triple-differential dijet cross section in proton-proton collisions at s=8TeV and constraints on parton distribution functions.

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.

EP Research Conference - Journal Club

Presented by: Drs. Chris Cheung and Dr. Ed Gerstenfeld

Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation.